Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
European Journal of Nuclear Medicine and Molecular Imaging
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging 12/2018

30.08.2018 | Guidelines

The SNMMI and EANM practice guideline for renal scintigraphy in adults

verfasst von: M. Donald Blaufox, Diego De Palma, Andrew Taylor, Zsolt Szabo, Alain Prigent, Martin Samal, Yi Li, Andrea Santos, Giorgio Testanera, Mark Tulchinsky

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 12/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is an international scientific and professional organization founded in 1954 to promote the science, technology, and practical application of nuclear medicine. The European Association of Nuclear Medicine (EANM) is a professional nonprofit medical association that facilitates communication worldwide between individuals pursuing clinical and research excellence in nuclear medicine. The EANM was founded in 1985. SNMMI and EANM members are physicians, technologists, and scientists specializing in the research and practice of nuclear medicine.

Methods

The SNMMI and EANM will periodically define new guidelines for nuclear medicine practice to help advance the science of nuclear medicine and to improve the quality of service to patients throughout the world. Existing practice guidelines will be reviewed for revision or renewal, as appropriate, on their fifth anniversary, or sooner, if indicated.

Conclusion

Each practice guideline, representing a policy statement by the SNMMI/EANM, has undergone a thorough consensus process in which it has been subjected to extensive review. The SNMMI and EANM recognize that the safe and effective use of diagnostic nuclear medicine imaging requires specific training, skills, and techniques, as described in each document. Reproduction or modification of the published practice guideline by entities not providing these services is not authorized.
Literatur
1.
Sfakianakis GN, Sfakianakis ED. Nuclear medicine in pediatric urology. J Nucl Med. 1988;29:1287–300.PubMed
2.
Boubaker A, Prior JO, Meuwly JY, Bischof-Delaloye A. Radionuclide investigations of the urinary tract in the era of multimodality imaging. J Nucl Med. 2006;47:1819–36.
3.
De Palma D, Santos AI. Renal radionuclide imaging: an evergreen forty years old. Klin Padiatr. 2014;226:225–32.CrossRef
4.
Blaufox MD. Procedures of choice in renal nuclear medicine. J Nucl Med. 1991;32:1301–9.PubMed
5.
Rado JP, Bano C, Tako J. Radioisotope renography during furosemide (Lasix) diuresis. Nucl Med Commun. 1968;7:212–21.
6.
O’Reilly PH, Testa HJ, Lawson RS, et al. Diuresis renography in equivocal urinary tract obstruction. Br J Urol. 1978;50:76–80.CrossRef
7.
O’Reilly PH. Diuresis renography: recent advances and recommended protocols. Br J Urol. 1992;69:113–20.CrossRef
8.
O’Reilly P, Britton K, et al. Consensus report on diuresis renography for investigating the dilated upper urinary tract. J Nucl Med. 1996;37:1872–6.PubMed
9.
Taylor AT, Blaufox MD, De Palma D, et al. A guidance document for structured reporting of diuresis renography. Semin Nucl Med. 2012;42:41–8.CrossRefPubMedCentral
10.
Taylor A, Nally J, Aurell M, et al. Consensus report on ACE inhibitor renography for detecting renovascular hypertension. Radionuclides in Nephrourology Group. Consensus group on ACEI renography. J Nucl Med. 1996;37(11):1876–82.PubMed
11.
Taylor A. ACE inhibition renography in the evaluation of suspected renovascular hypertension. In: Prigent A, Piepsz A, editors. Functional imaging in nephrourology. London: Taylor and Francis; 2006. p. 149–64.CrossRef
12.
Prigent A, Chaumet-Riffaud P. Clinical problems in renovascular disease and the role of nuclear medicine. Semin Nucl Med. 2014;44:110–22.CrossRef
13.
Hilson AJ, Maisey MN, Brown CB, et al. Dynamic renal transplant imaging with Tc-99m DTPA (Sn) supplemented by a transplant perfusion index in the management of renal transplants. J Nucl Med. 1978;19(9):994–1000.PubMed
14.
Kirchner PT, Goldman MH, Leapman SB, Kiepfer RF. Clinical application of the kidney to aortic blood flow index (K/A ratio). Contrib Nephrol. 1978;11:120–6.CrossRef
15.
Li Y, Russell CD, Palmer-Lawrence J, Dubovsky EV. Quantitation of renal parenchymal retention of technetium-99m-MAG3 in renal transplants. J Nucl Med. 1994;35(5):846–50.PubMed
16.
Dubovsky EV, Russell CD, Bischof-Delaloye A, et al. Report of the radionuclides in Nephrourology committee for evaluation of transplanted kidney (review of techniques). Semin Nucl Med. 1999;29(2):175–88.CrossRef
17.
De Palma D, Manzoni GA. Different imaging strategies in febrile urinary tract infection in childhood. What, when, why? Pediatr Radiol. 2013;43(4):436–43.CrossRef
18.
Tubis M, Posnick E, Nordyke RA. Preparation and use of I-131 labeled sodium iodohippurate in kidney function test. Proc Soc Exp Biol Med. 1960;103:497–8.CrossRef
19.
Fritzberg AR, Kasina S, Eshima D, Johnson DL. Synthesis and biological evaluation of Tc-99m MAG3 as a hippuran replacement. J Nucl Med. 1986;27:111–6.PubMed
20.
Russell CD, Dubovsky EV. Reproducibility of single-sample clearance of 99mTc-mercaptoacetyltriglycine and 131I-Orthoiodohippurate. J Nucl Med. 1999;40:1122–4.PubMed
21.
Müller-Suur R, Müller-Suur C. Glomerular filtration and tubular secretion of MAG-3 in the rat kidney. J Nucl Med. 1989;30(12):1986–91.PubMed
22.
Bubeck B, Brandau W, Eisenhurt M, et al. The tubular extraction rate (TER) of Tc-99m MAG3: a new quantitative parameter for renal parameter of renal function. Nucl Compact. 1987;18:260–7.
23.
Hauser W, Atkins HL, Nelson KG, Richards P. Technetium-99m DTPA: a new radiopharmaceutical for brain and kidney scanning. Radiology. 1970;94(Issue 3).CrossRef
24.
Chantler C, Barratt TM. Estimation of glomerular filtration rate from plasma clearance of 51Cr-edetic acid. Arch Dis Child. 1972;47:613–7.CrossRefPubMedCentral
25.
Stacy BD, Thorburn GD. Chromium-51 ethylenediaminetetraacetate for estimation of glomerular filtration rate. Science. 1966;152(3725):1076–7.CrossRef
26.
Boyd RE, Robson J, Hunt FC, et al. 99mTc gluconate complexes for renal scintigraphy. Br J Radiol. 1973;46(548):604–12.CrossRef
27.
Lin TH, Khentigan A, Winchell HS. A 99mTc-chelate substitute for organoradiomercurial renal agents. J Nucl Med. 1974;15(1):34–5.PubMed
28.
Willis KW, Martinez DA, Hedley-Whyte ET, et al. Renal localization of 99mTc-stannous glucoheptonate and 99mTc-stannous dimercaptosuccinate in the rat by frozen section autoradiography. The efficiency and resolution of technetium-99m. Radiat Res. 1977;69(3):475–88.CrossRef
29.
Yee CA, Lee HB, Blaufox MD. DMSA renal uptake: influence of biochemical and physiologic factors. J Nucl Med. 1981;22(12):1054–8.PubMed
30.
ICRP publication 80. Absorbed doses. Radiation dose to patients from radiopharmaceuticals. Addendum 2 to ICRP publication. Oxford: Pergamon Press; 1998.
31.
Stabin M, Taylor A, Eshima D, et al. Radiation dosimetry for technetium-99m-DTPA, and iodine-131-OIH based on human biodistribution studies. J Nucl Med. 1992;33:33–40.PubMed
32.
Fommei E, Ghione S, Hilson AJW, et al. Captopril radionuclide test in renovascular hypertension: a European multicentre study. Eur J Nucl Med. 1993;20:617–23.CrossRef
33.
Taylor AT Jr, Fletcher JW, Nally JV Jr, et al. Procedure guideline for diagnosis of renovascular hypertension. Society of Nuclear Medicine. J Nucl Med. 1998;39(7):1297–302.PubMed
34.
Piepsz A, Colarinha P, Gordon I, et al. Guidelines for 99mTc-DMSA scintigraphy in children. Eur J Nucl Med. 2001;28(3):BP37–41. Revision 2010 on linePubMed
35.
Piepsz A, Dobbeleir A, Ham HR. Effect of background correction on separate technetium-99m-DTPA renal clearance. J Nucl Med. 1990;31:430–5.PubMed
36.
Lythgoe MF, Gordon I, Khader Z, et al. Assessment of various parameters in the estimation of differential renal function using technetium-99m mercaptoaccetyltriglycine. Eur J Nucl Med. 1999;26:155–62.CrossRef
37.
Lezaic L, Hodolic M, Fettich J, et al. Reproducibility of 99mTc-mercaptoacetyltriglycine renography: population comparison. Nucl Med Commun. 2008;29:695–704.CrossRef
38.
Caglar M, Gedik GK, Karabulut E. Differential renal function estimation by dynamic renal scintigraphy: influence of background definition and radiopharmaceutical. Nucl Med Commun. 2008;29:1002–5.CrossRef
39.
Rutland MD. Glomerular filtration rate using 99mTc DTPA and a gamma camera. Eur J Nucl Med. 1983;4:425–33.
40.
Gordon I, Piepsz A, Sixt R. Guidelines for standard and diuretic renogram in children. Eur J Nucl Med Mol Imaging. 2011;38(6):1175–88.CrossRef
41.
Blaufox MD. Editorial comments: renal background correction and measurement of split renal function: the challenge. Eur J Nucl Med Mol Imaging. 2016;43:548–9.CrossRef
42.
Fine EJ, Blaufox MD, On Behalf of the Albert Einstein College of Medicine/Cornell University Medical Center Collaborative Hypertension Group. The Einstein/Cornell collaborative protocol to assess efficacy and methodology in captopril scintirenography. Am J Hypertens. 1991;4:716S–20S.CrossRef
43.
Prigent A, Cosgriff P, Gates GF, et al. Consensus report on quality control of quantitative measurements of renal function obtained from the renogram: international consensus committee from the scientific Committee of Radionuclides in Nephrourology. Semin Nucl Med. 1999;29(2):146–59.CrossRef
44.
Delpassand ES, Homayoon K, Madden T, et al. Determination of glomerular filtration rate using a dual-detector gamma camera and the geometric mean of renal activity: correlation with the Tc-99m DTPA plasma clearance method. Clin Nucl Med. 2000;25(4):258–62.CrossRef
45.
Blaufox MD, Aurell M, Bubeck B, et al. Report of the radionuclides in nephrourology committee on renal clearance. J Nucl Med. 1996;37(11):1883–90.PubMed
46.
Gates GF. Glomerular filtration rate: estimation from fractional renal accumulation of 99mTc-DTPA (stannous). AJR Am J Roentgenol. 1982;138(3):565–70.CrossRef
47.
Schlegel JU, Hamway SA. Individual renal plasma flow determination in 2 minutes. J Urol. 1976;116(3):282–5.CrossRef
48.
Tauxe WN, Dubovsky EV, Kidd T Jr, et al. New formulas for the calculation of effective renal plasma flow. Eur J Nucl Med. 1982;7(2):51–4.CrossRef
49.
Taylor A Jr, Corrigan PL, Galt J, et al. Measuring technetium-99m-MAG3 clearance with an improved camera-based method. J Nucl Med. 1995;36:1689–95.PubMed
50.
Piepsz A, Colarinha P, Gordon I, et al. Guidelines for glomerular filtration rate determination in children. Eur J Nucl Med. 2001;28(3):BP31–6.PubMed
51.
Itoh K. Comparison of methods for determination of glomerular filtration rate: Tc-99m-DTPA renography, predicted creatinine clearance method and plasma sample method. Ann Nucl Med. 2003;17(7):561–5.CrossRef
52.
Cosgriff PS, Lawson RS, Nimmon CC. Towards standardization in gamma camera renography. Nucl Med Commun. 1992;13:580–5.CrossRef
53.
Fleming JS. A technique for analysis of geometric mean renography. Nucl Med Commun. 2006;27:701–8.CrossRef
Metadaten
Titel
The SNMMI and EANM practice guideline for renal scintigraphy in adults
verfasst von
M. Donald Blaufox
Diego De Palma
Andrew Taylor
Zsolt Szabo
Alain Prigent
Martin Samal
Yi Li
Andrea Santos
Giorgio Testanera
Mark Tulchinsky
Publikationsdatum
30.08.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 12/2018
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-018-4129-6

Weitere Artikel der Ausgabe 12/2018

European Journal of Nuclear Medicine and Molecular Imaging 12/2018 Zur Ausgabe

Original Article

Comparison of the clinical performance of upper abdominal PET/DCE-MRI with and without concurrent respiratory motion correction (MoCo)

Letter to the Editor

Delivering PET imaging results to cancer patients: steps for handling ethical issues

Original Article

FDG PET-derived parameters as prognostic tool in progressive malignant pleural mesothelioma treated patients

Original Article

Sodium-fluoride PET-CT for the non-invasive evaluation of coronary plaques in symptomatic patients with coronary artery disease: a cross-correlation study with intravascular ultrasound

Original Article

What is the prognostic impact of FDG PET in locally advanced head and neck squamous cell carcinoma treated with concomitant chemo-radiotherapy? A systematic review and meta-analysis

Original Article

Prognostic value of posttreatment 18F-FDG PET/CT and predictors of metabolic response to therapy in patients with locally advanced cervical cancer treated with concomitant chemoradiation therapy: an analysis of intensity- and volume-based PET parameters